venBio Partners logo

venBio Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Equity

Axonis Therapeutics logo
Axonis Therapeutics

Biotechnology

venBio Partners logo
Sofinnova Investments logo
Solasta Ventures logo
SCI Ventures logo
Tachyon Ventures logo
Perceptive Advisors logo
MRL Ventures Fund logo
Lumira Ventures logo

Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

Series A
$115M
10/30/2024
Article
Vicebio logo
Vicebio

Biopharmaceutical

TCGX logo
venBio logo
UniQuest logo
Medicxi logo
Goldman Sachs Alternatives logo
Avoro Ventures logo

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

Series B
$100M
09/23/2024
Article
Candid Therapeutics logo
Candid Therapeutics

Biotechnology

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo
Soleus Capital logo
Samsara BioCapital logo
Redmile Group logo
Polaris Innovation Fund logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article